Community Health Network Pays $345 Million to Settle Stark Law Case
Posted 12/21/23
FCA Federal
This archive displays posts tagged as relevant to the federal False Claims Act. You may also be interested in the following pages:
December 21, 2023
A Florida woman who submitted over $192 million in claims to Medicare for medically unnecessary and unprovided tests, equipment, and services, has been sentenced to 20 years in prison. Elizabeth Hernandez ordered thousands of genetic testing and orthotic braces for patients she never spoke to or examined, ultimately ordering more cancer genetic tests than any other provider in the nation. She also billed for thousands of telemedicine visits that she never performed, often billing for over 24 hours in a single day. DOJDecember 21, 2023
Ultragenyx Pharmaceutical, Inc., maker of Crysvita, will pay $6 million for violating the False Claims Act. Crysvita is prescribed to treat a rare inherited blood disorder, which may require a genetic test to definitively diagnose. To induce purchases and referrals, Ultragenyx paid a laboratory to conduct genetic tests at no cost to healthcare providers or patients, and then provide the results reports to Ultragenyx. Ultragenyx then used the positive test results reports to target healthcare providers for Crysvita sales. Internally, Ultragenyx referred to this kickback scheme as their "sponsored" testing program. The program was exposed via a qui tam whistleblower, who will receive $1.07 million of the $6.7 million recovery. DOJDecember 19, 2023
Indiana-based Community Health Network Inc. has agreed to pay $345 million to resolve claims by its former CFO and COO Thomas Fischer, which alleged the healthcare system submitted claims to Medicare that were tainted by violations of the Stark Law. In order to capture physicians’ downstream referrals, Community paid physicians salaries that were sometimes double market rate, and awarded them bonuses based on the number of referrals. Community then submitted claims resulting from these referrals for reimbursement. DOJDecember 18, 2023
Heart monitoring device manufacturer BioTelemetry Inc. and its subsidiary, LifeWatch Services Inc., have agreed to pay more than $14.7 million for causing false claims to be submitted to federal healthcare programs. The claims were brought in two separate qui tam suits, one by an employee of one of LifeWatch’s customers, Michael Pelletier, and the other by SFP I LLC. The whistleblowers alleged that the companies knew the design of their enrollment portal would steer clinical staff into enrolling patients in telemetry, which is reimbursed at a higher rate, rather than holter monitoring and event monitoring, which is reimbursed at a lower rate. DOJCatch of the Week: King Kong Tools
Posted 11/30/23
Alabama Court Reaffirms Constitutionality of False Claims Act
Posted 11/29/23
Tactical Gear Company Settles $2.1 Million False Claims Act Allegations
Posted 11/22/23
The U.S Attorney’s Office in the Southern District of Ohio has announced that London Bridge Trading Company, Ltd. (LBT), a Virginia headquartered manufacturer of tactical gear for military, law enforcement, and other organizations, has agreed to pay nearly $2.1 million to settle False Claims Act allegations. The case, initiated by qui tam relator Ann Keating, involves accusations that LBT failed to comply with the...
$45.6 Million Settlement in False Claims Act Case Against Nursing Facility Defendants
Posted 11/17/23
